- Home
- SUZ vs RVTY Comparison
SUZ vs RVTY Comparison
Compare SUZ & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUZ | RVTY |
|---|---|---|
| Founded | 1924 | 1937 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 9.7B |
| IPO Year | 2002 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SUZ | RVTY |
|---|---|---|
| Price | $8.88 | $101.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $109.67 |
| AVG Volume (30 Days) | ★ 2.5M | 1.2M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.15% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $13.28 | $6.37 |
| Revenue Next Year | $13.57 | $5.10 |
| P/E Ratio | ★ $5.58 | $47.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.52 | $81.22 |
| 52 Week High | $11.54 | $118.30 |
Technical Indicators
Market Signals| Indicator | SUZ | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 67.59 |
| Support Level | $8.80 | $82.88 |
| Resistance Level | $9.66 | $103.04 |
| Average True Range (ATR) | 0.18 | 4.33 |
| MACD | -0.01 | 1.56 |
| Stochastic Oscillator | 30.08 | 97.72 |
Price Performance
Historical ComparisonAbout SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.